Impact of Irinotecan and Oxaliplatin on Overall Survival in Patients With Metastatic Colorectal Cancer: A Population-Based Study
Author:
Affiliation:
1. Division of Medical Oncology; and Population and Preventive Oncology, British Columbia Cancer Agency, Vancouver; and Division of Medical Oncology, British Columbia Cancer Agency, Victoria, British Columbia, Canada
Abstract
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Health Policy,Oncology (nursing),Oncology
Link
http://ascopubs.org/doi/pdfdirect/10.1200/JOP.0942001
Reference17 articles.
1. Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.
2. Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer.
3. Weekly high-dose leucovorin versus low-dose leucovorin combined with fluorouracil in advanced colorectal cancer: results of a randomized multicenter trial. Study Group for Palliative Treatment of Metastatic Colorectal Cancer Study Protocol 1.
4. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial
5. Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. TAS-102 Monotherapy and Combination Therapy with Bevacizumab for Metastatic Colorectal Cancer;Gastroenterology Research and Practice;2021-12-20
2. The Downregulation of lncRNA pgm5-as1 Inhibits the Proliferation and Metastasis Via Increasing miR-484 Expression in Colorectal Cancer;Cancer Biotherapy and Radiopharmaceuticals;2021-03-01
3. A meta-analysis comparing regorafenib with TAS-102 for treating refractory metastatic colorectal cancer;Journal of International Medical Research;2020-07
4. Four lines of immunochemotherapy combinations in a young patient with an aggressive metastatic colorectal cancer;memo - Magazine of European Medical Oncology;2020-06-30
5. KRAS amplification in metastatic colon cancer is associated with a history of inflammatory bowel disease and may confer resistance to anti-EGFR therapy;Modern Pathology;2020-05-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3